期刊名称：EPILEPSIA
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
|
|
Epilepsia is the leading, most authoritative source for current clinical and research results on all aspects of epilepsy. As the journal of the International League Against Epilepsy, Epilepsia presents subscribers with scientific evidence and clinical methodology in: clinical neurology, neurophysiology, molecular biology, neuroimaging, neurochemistry, neurosurgery, pharmacology, neuroepidemiology, and therapeutic trials. Each monthly issue features original peer reviewed articles, progress in epilepsy research, brief communications, editorial commentaries, special supplements, meeting reports, book reviews, and announcements | |
|
Instructions to Authors
Epilepsia is the official journal of The International League Against Epilepsy. It publishes original articles on all clinical and experimental aspects of epilepsy.
Editorial Policies
A manuscript is accepted with the understanding that the material has not been previously published, except in abstract form, and that it is not simultaneously under consideration by any other journal. As a condition of publication, Epilepsia requires authors to transfer copyright to the International League Against Epilepsy. A copyright transfer form will be sent to authors for signature at the time receipt of the manuscript is acknowledged. Epilepsia complies with recommendations of the International Committee of Medical Journal Editors on ¡°Conflict of Interest¡± (see Ann Intern Med 1993;118:646). The cover letter must advise the Editor-in-Chief of any actual or potential financial or other conflict of interest related to the submitted manuscript. This requirement applies to all authors and includes disclosure of all commercial considerations (ownership, equity position, stock options, consulting fees, patent rights, and corporate affiliations) associated with any drug, product, process, or commercial laboratory mentioned in the submitted material. Disclosure will be made at the time of publication in a form mutually agreed on by the Editor-in-Chief and the author(s). Failure to comply with conflict of interest requirements may result in rejection of the manuscript, retraction of the published article, and a ban on future submissions by the author(s). In submitting a manuscript, the corresponding author acknowledges that all co-authors have seen and approved the final version of the paper and accept responsibility for the data presented. The Editor reserves the right to require authors to submit their original data for comparison with the manuscript's illustrations, tables, and results.
All manuscripts submitted to Epilepsia are subject to peer review and acceptance is never guaranteed. Two reviews are generally obtained for each submission; additional opinions are sought when there are substantial differences between reviewers. Where appropriate, specific reviews are also obtained for statistical adequacy. Decisions of the Editor and Editorial Board are final. Revisions of previously rejected manuscripts will not be considered.
Epilepsia will consider full-length original articles, brief communications, and letters. Invited reviews, editorial commentaries, book reviews, and notices of meetings and awards are also published.
Original articles are not limited in length, but authors should aim for clarity, brevity, and directness. Prolixity is the greatest barrier between author and reader. Writers not fluent in English should seek assistance to ensure proper grammar and syntax.
Brief Communications and Case Reports may not exceed 1,500 words and are limited to 15 references and three figures or tables. Case reports will only be peer-reviewed if judged to have a clear cause-effect relationship among the phenomena under discussion, and to be of very broad readership interest.
Letters should not exceed 500 words, have no more than six citations, and contain no figures or graphics. Epilepsia accepts "Original letters" and "Comment letters." Original letters should report original, previously unpublished material. Original letters are appropriate for most case reports. Original letters are subject to peer-review, and will be so listed. Comment letters are in response to a previously published article
in Epilepsia, and need not present original material. Comment letters are published at the discretion of the Editor.
Editorial commentaries, critical reviews, and book reviews are by invitation only.
Rapid Communications
We will consider rapid publication of brief papers of original work that are of particular importance and timeliness. Although papers in any category will be considered for expedited publication, we particularly encourage submissions related to the molecular and cellular biology of epilepsy, and to the outcomes of rigorous and definitive clinical trials.
Manuscripts for expedited publication should not exceed 12 pages. Figures, tables, and references must adhere to additional requirements specified in the Instructions to Authors. Decisions on acceptability will be made within one month, and papers will be published within eight weeks of acceptance. The Editor-in-Chief will determine the suitability of manuscripts for rapid publication, and his decision is final.
Manuscript Preparation
Manuscripts should be submitted for review via the journal's website: http://epilepsia.manuscriptcentral.com.
New accounts can be created from the home page. Prepare your manuscript (text and tables) using a word processing program and save as a .doc or .rtf file. Save each figure as a separate electronic file, preferably named as figure1.tif or fig2.jpg. Manuscript Central Version 1.6 supports most image file formats including PowerPoint and Excel. Detailed formatting instructions for electronic manuscript submission are available at http://epilepsia.manuscriptcentral.com.
Place the lead author's name and the page number in the upper right hand corner of all pages. Number pages consecutively beginning with the title page, including references, tables, and figure legends.
Epilepsia follows the recommendations of the International Committee of Medical Journal Editors concerning the order of authors and protection of patient anonymity (see BMJ 1991;302:1193).
Spell out numbers below 10 or that are used at the beginning of sentences; use Arabic numerals for numbers above 10 and for units of measure.
Form of Manuscript
Title Page: This should include the manuscript's full title, authors' first and last names, institutional affiliations, key words for use by abstracting services, and a running title of no more than 40 characters. Give the name, address, telephone number, fax number, and e-mail address of the corresponding author.
Abstract: On a separate page, provide a summary of not more than 250 words. The abstract must be structured and consist of four paragraphs, labeled Purpose, Methods, Results, and Conclusions. Each section of the structured abstract should concisely and specifically describe why and how the study was performed, the essential results, and what the authors conclude from the results. To promote brevity while still including all essential information, authors may use phrases rather than complete sentences. For more detailed guidelines regarding preparation of structured abstracts, see Ann Intern Med 1990;113:69 (Appendixes 1 and 2).
Introduction: This should state the paper's objective briefly and clearly with reference to previous work.
Methods: These should be described in sufficient detail that the work can be duplicated, or by reference to previous descriptions if they are readily available. Identify the statistical procedures that were used and the rationale for choosing a particular method, especially if it is not standard. Reports of experimental studies on humans must certify that the research received prior approval by the appropriate institutional review body and that informed consent was obtained from each volunteer or patient. Studies involving animals must include a statement that their care and use conformed to institutional policies and guidelines. When animals are subjected to invasive procedures, explicit details must be provided regarding the steps taken to eliminate pain and suffering, including the specific anesthetic or other drugs used, the amounts of these agents, and the frequency of their administration. Submissions not adhering to these principles will be rejected.
Results: These should be described concisely and in logical order. Where possible, use figures or tables to present data rather than text. When appropriate, give the range, SD (standard deviation) or ME (mean error), and indicate the significance of differences between numerical values. Express clinical laboratory data in conventional rather than SI units. Authors may choose to give SI units in parentheses.
Discussion: This section should interpret the results and assess their significance in relation to previous work in the field. Avoid speculation not warranted by actual data.
Acknowledgments: These should be typed on a separate sheet and kept to a minimum consistent with the requirements of courtesy and disclosure.
References: Effective with all new submissions cite references by number in text. Type references double-spaced on separate sheets. List in order of citation, by number. Provide all authors names when fewer than seven; when seven or more, list the first three authors only, followed by et al. Give complete article titles and inclusive page numbers. Use Index Medicus abbreviations for journals. Make sure that all numbered references in the text correspond to the correct citation in the List of References. Accuracy of reference data is the responsibility of the author.
Sample References:
Journal article:
Lancman ME, Asconape JJ, Penry JK. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 1994;35:302-306.
Book: Kessler JA, Apsel S. The epilepsy handbook: the practical management of seizures. 2nd edition. New York: Raven Press, 1994.
Chapter in a book:
Fisher RS, Uthman BM, Ramsay RE, et al. Alternative surgical techniques for epilepsy. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1993:549.
Publication
Text: Authors must submit the accepted, corrected final version of their manuscript on a 3.5-inch (9 cm) diskette. MS Word in a Windows-compatible format is preferred. If you must submit a Macintosh disk, download the file in an IBM format, if possible. Diskettes must be labeled with the authors' names, journal title, article title, hardware and software used, and the manuscript file's name. When indicating the word processing program used, specify the version number. The manuscript submitted on disk must be identical to the final accepted version of the manuscript.
Figures: We are happy to receive your final artwork in digital format. Please save line artwork (vector graphics) as Encapsulated PostScript (EPS) and bitmap files (halftones or photographic images) as Tagged Image Format (TIFF), with a resolution of at least 300 dpi at final size. Do not send native file formats. More detailed information on the submission of electronic artwork can be found at http://www.blackwell-science.com/elecmed/digill.htm. Otherwise, authors will be asked to submit clear, glossy prints of each figure upon acceptance for publication. Each figure should be labeled on the back with the figure number, name of the lead author, and an arrow indicating the top. All figures should be prepared professionally. Ordinate and abscissa should be labeled, and any calibration clearly indicated. Lettering must be large enough to be easily legible when reduced for publication. The maximum final size of any figure in the Journal will be 17 x 22.5 cm. Photographs of patients must be accompanied by a signed release authorizing publication. Masking eyes, while desirable, is not sufficient. Color figures can be used if essential but require permission of the Editor. Author costs for reproduction of color figures will be determined on an individual basis.
Figure legends: Figure legends should be numbered sequentially and typed double-spaced on a separate sheet of paper. In addition to the original figures, provide two sets of photocopies. Explain all symbols and abbreviations used in each figure. Written permission must be included with the manuscript if non-original material is to be reproduced. Credit the original source in the legend.
Tables: Authors should format tables the way they want them to appear in print. Each table should be given a title and fit on a single manuscript page. Provide notes and explanations of abbreviations below the table. Do not duplicate data in tables and figures. Written permission must be included with the manuscript if non-original material is to be reproduced. Credit the original source at the bottom of the table.
Details of Style
Use international non-proprietary (generic) names when referring to drugs (see Epilepsia 1993;34:1151); avoid proprietary (brand) names. All acronyms are spelled out at first mention. The following abbreviations, if used, need not be written out: CNS, CSF, EEG.
Proofs and Reprints
Proofs must be returned within three days of receipt. Late return of proofs may cause publication of the article to be delayed. Please check text, tables, legends, and references carefully. It may be necessary to charge for alterations other than correction of printing errors. An order form for reprints will be included with proofs. Return proofs to Cynthia Korisky, Blackwell Publishing, Commerce Place, 350 Main Street, Malden, MA 02148; Fax: (781) 338-8322; E-mail: ckorisky@blackwellpub.com.
Announcements
Announcements of congresses, meetings, courses, awards, and other items likely to be of interest to the readers of Epilepsia should be submitted to the Editorial Office.
Indicate the name and address of the person from whom additional information can be obtained.
Mailing
Authors who are unable to submit via the journal's website should send submissions by express or first-class mail (airmail from overseas) to: Robert S. Fisher, M.D., Ph.D., Editor-in-Chief, Epilepsia, Stanford Comprehensive Epilepsy Center, Room H3110, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5235; Tel: (650) 498-6385; Fax: (650) 498-6326; E-mail: epilepsy@stanford.edu. Do NOT send material by certified or registered mail. An acknowledgment will be mailed upon receipt of the manuscript in the Editorial Office. Manuscripts and illustrations will not be returned to authors unless specifically requested at the time of initial submission. Authors are therefore advised to keep a clean manuscript copy and negatives of all photographic prints.
Books for Review should be sent to: Richard S. McLachlan, M.D., Department of Neurology, Shaikh Khalifa Medical Center, P.O. Box 51900, Abu Dhabi, United Arab Emirates.
Supplements and Publications of Proceedings of Meetings can be published. Guidelines for preparing supplements and our Journal's policies regarding supplements are published each year in the January issue. Address all inquiries to the Supplements Editor: Gregory K. Bergey, M.D., Department of Neurology, Meyer 2-147, Johns Hopkins School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287.
Editorial Board
Editor-In-Chief
Robert S. Fisher
Supplements Editor
Gregory K. Bergey
Editor, Epilepsia Digest
Rajendra Kale
Book Review Editor
Simon D. Shorvon
Editorial Board Members
Joan K. Austin, Indianapolis, USA
Tallie Z. Baram, Irvine, USA
Charles E. Begley, Houston, USA
Larry S. Benardo, Brooklyn, USA
Yehezkel Ben-Ari, Paris, France
Anne T. Berg, DeKalb, USA
Meir Bialer, Jerusalem, Israel
Carol Camfield, Halifax, Canada
Arturo Carpio, Cuenca, Ecuador
Douglas A. Coulter, Philadelphia, USA
Amadou Gallo Diop, Dakar, Senegal
Lars Forsgren, Umea, Sweden
R. Guerrini, London, UK
Olaf Henriksen, Sandvika, Norway
Bruce Hermann, Madison, USA
Juoko I. T. Isojarvi, Oulo, Finland
Graeme D. Jackson, Victoria, Australia
Ruben I. Kuzniecky, Birmingham, USA
Daniel Lowenstein, San Francisco, USA
Robert L. Macdonald, Ann Arbor, USA
Beth A. Malow, Ann Arbor, USA
Istvan Mody, Los Angeles, USA
Soheyl Noachtar, Munich, Germany
Jeffrey L. Noebels, Houston, USA
Emilio Perucca, Pavia, Italy
Perrine Plouin, Paris France
Rebecca Rausch, Los Angeles, USA
Charles E. Ribak, Irvine, USA
J.W.A.S. Sander, Bunkinghamshire, UK
Mitsumoto Sato, Sendai, Japan
Helen E. Scharfman, West Haverstraw, USA
Ingrid E. Scheffer, West Heidelberg, Australia
Eva Bettina Schmitz, Berlin, Germany
Masakazu Seino, Shizuoka, Japan
Susan Spencer, New Haven, USA
Hermann Stefan, Erlangen, Germany
Ortrud K. Steinlein, Bonn, Germany
Nancy Temkin, Seattle USA
Walter van Emde-Boas, Heemstede, The Netherlands
Federico Vigevano, Rome,Italy
Harry Vinters, Los Angeles, USA
Claude G. Wasterlain, Sepulveda, USA
Peter D. Williamson, Lebanon, USA
ILAE Executive Committee and Editorial Advisory Board
Giuliano Avanzini, Milan, Italy
Jerome Engel, Jr,. Los Angeles, USA
Natalio Fejerman, Buenos Aires, Argentina
Michael D. Hills, Hamilton, New Zealand
Richard Holmes, Dublin, Ireland
Yoshiaki Mayanagi, Tokyo, Japan
Timothy A. Pedley, New York, USA
Edward H. Reynolds, London, UK
Simon Shorvon, London, UK
Peter Wolf, Bielefeld, Germany
|
